K251218 is an FDA 510(k) clearance for the SafeBeat Rx App. This device is classified as a Computer, Diagnostic, Programmable (Class II - Special Controls, product code DQK).
Submitted by Safebeat Rx, Inc. (San Francisco, US). The FDA issued a Cleared decision on February 6, 2026, 291 days after receiving the submission on April 21, 2025.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1425.
| 510(k) Number | K251218 FDA.gov |
| FDA Decision | Cleared Substantially Equivalent - Traditional 510(k) (SESE) |
| Date Received | April 21, 2025 |
| Decision Date | February 06, 2026 |
| Days to Decision | 291 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | DQK - Computer, Diagnostic, Programmable |
| Device Class | Class II - Special Controls |
| CFR Regulation | 21 CFR 870.1425 |